Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM25980 Fibroblast

Description:

MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34; MRT34
CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN; CRADD

Affected:

Yes

Sex:

Female

Age:

17 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Cell Type Fibroblast
Tissue Type Skin
Transformant Untransformed
Race White
Ethnicity Not Hispanic/Latino
Ethnicity Old Order Mennonite
Country of Origin USA
Family Member 1
Family History Y
Relation to Proband proband
Confirmation Molecular characterization before cell line submission to CCR
Species Homo sapiens
Common Name Human
Remarks Clinically affected; relative macrocephaly: OFC 65th percentile for age, 7th percentile for height and weight; moderate intellectual disability; normal development until age 2 years when speech and language delays became more apparent; spoke single words at 3 years of age; spoke sentences of two or more years at 4-5 years of age; impulsive, inattentive, and distractible behavior: lacks stranger anxiety and generally exhibits impulsive and disinhibited behavior; pachygyria diagnosed by MRI at age 2 years: thickened cortical gray matter of the frontal, parietal, and temporal lobes, with a distinct gray-white margin and simplified gyral pattern; brief episodes of blank staring and eye fluttering noted and diagnosed as epilepsy; EEG performed at age 4 years showed multiple brief bilateral polyspike and spike-wave discharges; staring episodes continued on a regular basis but are well-controlled with medication; whole exome sequencing revealed a homozygous autosomal recessive mutation c.382G>C (p.Gly128Arg) in the CRADD gene; GM25981 is the unaffected carrier mother; has affected sister (not in catalog).

Characterizations

back to top
PDL at Freeze 4.49
Passage Frozen 2
 
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by LINE assay
 
Gene CRADD
Chromosomal Location 12q22
Allelic Variant 1 603454.p.Gly128Ar; MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34
Identified Mutation c.382G>C; In 5 Mennonite patients with autosomal recessive nonsyndromic mental retardation-34 (MRT34; 614499), Puffenberger et al. (2012) identified a homozygous 382G-C transversion in the CRADD gene, resulting in a gly128-to-arg (G128R) substitution in a highly conserved residue in the CRADD death domain. The mutation was found by homozygosity mapping followed by exome sequencing. Seven heterozygous carriers of this mutation were found among 203 Mennonite control samples, yielding a population-specific allele frequency of 1.72%. (Puffenberger (2012) stated that the correct population-specific allele frequency data appear in Table 4; corresponding data in the text are incorrect.) Overexpression of mutant murine Cradd with the G128R mutation showed normal protein localization to the nucleus and cytoplasm. However, when co-overexpressed with wildtype Pidd (605247), mutant G128R Cradd formed large cytoplasmic aggregates with a relative loss of Cradd expression in the nucleus. The findings suggested that the G128R mutation alters 1 of the interaction surfaces of the CRADD death domain to decrease affinity for the PIDD death domain.
 
Gene CRADD
Chromosomal Location 12q22
Allelic Variant 2 603454.p.Gly128Ar; MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34
Identified Mutation c.382G>C; In 5 Mennonite patients with autosomal recessive nonsyndromic mental retardation-34 (MRT34; 614499), Puffenberger et al. (2012) identified a homozygous 382G-C transversion in the CRADD gene, resulting in a gly128-to-arg (G128R) substitution in a highly conserved residue in the CRADD death domain. The mutation was found by homozygosity mapping followed by exome sequencing. Seven heterozygous carriers of this mutation were found among 203 Mennonite control samples, yielding a population-specific allele frequency of 1.72%. (Puffenberger (2012) stated that the correct population-specific allele frequency data appear in Table 4; corresponding data in the text are incorrect.) Overexpression of mutant murine Cradd with the G128R mutation showed normal protein localization to the nucleus and cytoplasm. However, when co-overexpressed with wildtype Pidd (605247), mutant G128R Cradd formed large cytoplasmic aggregates with a relative loss of Cradd expression in the nucleus. The findings suggested that the G128R mutation alters 1 of the interaction surfaces of the CRADD death domain to decrease affinity for the PIDD death domain.

Phenotypic Data

back to top
Remarks Clinically affected; relative macrocephaly: OFC 65th percentile for age, 7th percentile for height and weight; moderate intellectual disability; normal development until age 2 years when speech and language delays became more apparent; spoke single words at 3 years of age; spoke sentences of two or more years at 4-5 years of age; impulsive, inattentive, and distractible behavior: lacks stranger anxiety and generally exhibits impulsive and disinhibited behavior; pachygyria diagnosed by MRI at age 2 years: thickened cortical gray matter of the frontal, parietal, and temporal lobes, with a distinct gray-white margin and simplified gyral pattern; brief episodes of blank staring and eye fluttering noted and diagnosed as epilepsy; EEG performed at age 4 years showed multiple brief bilateral polyspike and spike-wave discharges; staring episodes continued on a regular basis but are well-controlled with medication; whole exome sequencing revealed a homozygous autosomal recessive mutation c.382G>C (p.Gly128Arg) in the CRADD gene; GM25981 is the unaffected carrier mother; has affected sister (not in catalog).

External Links

back to top
Gene Cards CRADD
Gene Ontology GO:0005515 protein binding
GO:0005622 intracellular
GO:0007165 signal transduction
GO:0008625 induction of apoptosis via death domain receptors
GO:0042981 regulation of apoptosis
NCBI Gene Gene ID:8738
NCBI GTR 603454 CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN; CRADD
614499 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34
OMIM 603454 CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN; CRADD
614499 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34

Culture Protocols

back to top
Cumulative PDL at Freeze 4.49
Passage Frozen 2
Split Ratio 1:5
Temperature 37 C
Percent CO2 5%
Percent O2 3%
Medium Eagles Minimum Essential Medium with Earle's salts:Dulbecco's modified MEM with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • 3311
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube